Gyon Technologies Capital Management, LP Novartis Ag Transaction History

Gyon Technologies Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$80.52 - $93.75 $619,923 - $721,781	-7,699 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$80.11 - $90.62 $616,766 - $697,683	7,699 New	7,699 $676,000
Q2 2021 Aug 16, 2021	SELL	$85.24 - $94.15 $471,547 - $520,837	-5,532 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$83.5 - $98.47 $269,955 - $318,353	3,233 Added 140.63%	5,532 $473,000
Q4 2020 Feb 16, 2021	BUY	$78.07 - $94.43 $179,482 - $217,094	2,299 New	2,299 $217,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.